Team:Vanderbilt/Home
From 2014.igem.org
(added home page) |
|||
Line 1: | Line 1: | ||
- | + | {{Team:Vanderbilt/CSS}} | |
+ | |||
<html> | <html> | ||
Line 5: | Line 6: | ||
<meta charset="UTF-8"> | <meta charset="UTF-8"> | ||
<title>Home</title> | <title>Home</title> | ||
- | |||
<style> | <style> | ||
Line 17: | Line 17: | ||
visibility: visible; | visibility: visible; | ||
} | } | ||
- | |||
#home_tab_right { | #home_tab_right { | ||
visibility: hidden; | visibility: hidden; | ||
Line 32: | Line 31: | ||
<div id="tabs"> | <div id="tabs"> | ||
- | + | <div id="home_tab_left" class = "tab_left"><a href="Home"></a> </div> | |
- | + | <div id="team_tab_left" class = "tab_left"><a href="Team"></a> </div> | |
- | + | <div id="project_tab_left" class = "tab_left"><a href="Project"></a> </div> | |
- | + | <div id="parts_tab_left" class = "tab_left"><a href="Parts"></a> </div> | |
- | + | <div id="notebook_tab_left" class = "tab_left"><a href="Notebook"></a> </div> | |
- | + | <div id="safety_tab_left" class = "tab_left"><a href="Safety"></a> </div> | |
- | + | <div id="attributions_tab_left" class = "tab_left"><a href="Attributions"></a> </div> | |
<a href="https://2014.igem.org/Main_Page"> | <a href="https://2014.igem.org/Main_Page"> | ||
- | <img id="igem_logo" src=" | + | <img id="igem_logo" src="https://static.igem.org/mediawiki/parts/6/6b/Vanderbilt_iGEM.png" alt="igem logo" width="50" height="50"> |
</a> | </a> | ||
- | + | <div id="home_tab_right" class = "tab_right"><a href="Home"> </div></a> | |
- | + | <div id="team_tab_right" class = "tab_right"><a href="Team"> </div></a> | |
- | + | <div id="project_tab_right" class = "tab_right"><a href="Project"> </div></a> | |
- | + | <div id="parts_tab_right" class = "tab_right"><a href="Parts"> </div></a> | |
- | + | <div id="notebook_tab_right" class = "tab_right"><a href="Notebook"> </div></a> | |
- | + | <div id="safety_tab_right" class = "tab_right"><a href="Safety"> </div></a> | |
- | + | <div id="attributions_tab_right" class = "tab_right"><a href="Attributions"> </div></a> | |
</div> | </div> | ||
Line 58: | Line 57: | ||
<p>Long before the advent of modern science, it was recognized that certain plants are | <p>Long before the advent of modern science, it was recognized that certain plants are | ||
capable of producing compounds of immense value.</p> | capable of producing compounds of immense value.</p> | ||
- | <img id="vial" class="var_page_img" src="Oils_vial_design.jpg" alt="Oils in a vial" width="297" height="244" > | + | <img id="vial" class="var_page_img" src="https://static.igem.org/mediawiki/parts/6/65/Oils_vial_design.jpg" alt="Oils in a vial" width="297" height="244"> |
<p>From a single class of molecule, the terpenoids, come properties including agents with therapeutic | <p>From a single class of molecule, the terpenoids, come properties including agents with therapeutic | ||
qualities against maladies ranging from cancer to infection, antimicrobials, natural pesticides, | qualities against maladies ranging from cancer to infection, antimicrobials, natural pesticides, | ||
Line 64: | Line 63: | ||
<p>However, the utilization of these remarkable compounds has been severely hindered by their rarity | <p>However, the utilization of these remarkable compounds has been severely hindered by their rarity | ||
in nature: many are found in only a small number of species and produced at levels measured in | in nature: many are found in only a small number of species and produced at levels measured in | ||
- | parts per | + | parts per million<sup>2</sup>. Synthetic biology offers an opportunity to resolve this problem, by applying |
metabolic engineering in order to create cellular factories. Our project seeks to use the ideas of | metabolic engineering in order to create cellular factories. Our project seeks to use the ideas of | ||
synthetic biology to develop a commercially viable strategy for the efficient production of a wide | synthetic biology to develop a commercially viable strategy for the efficient production of a wide |
Latest revision as of 23:08, 26 January 2015
Long before the advent of modern science, it was recognized that certain plants are capable of producing compounds of immense value.
From a single class of molecule, the terpenoids, come properties including agents with therapeutic qualities against maladies ranging from cancer to infection, antimicrobials, natural pesticides, rich flavorants, and fragrant scents.
However, the utilization of these remarkable compounds has been severely hindered by their rarity in nature: many are found in only a small number of species and produced at levels measured in parts per million2. Synthetic biology offers an opportunity to resolve this problem, by applying metabolic engineering in order to create cellular factories. Our project seeks to use the ideas of synthetic biology to develop a commercially viable strategy for the efficient production of a wide range of terpenoids.
We believe that common brewer's yeast, or Saccharomyces cerevisiae, is an excellent platform for engineering terpenoid biosynthetic pathways.
The mevalonic acid pathway endogenous to yeast produces the key isoprenoid intermediates that are the precursors to virtually all terpenoid biosynthesis3.
Genes encoding plant synthases can then be recombinantly expressed in yeast cells, which then take that isoprenoid substrate and convert it through one or more steps into the final terpenoid product.
A specially designed biobrick shuttle vector developed by our team should make the process convenient and reliable, by allowing us to first amplify plasmids containing our gene of interest in E. coli and permitting the integration of synthase genes directly into the yeast genome through homologous recombination.
A carefully-refined protocol is expected to further improve product yield, by extracting genetic sequences directly from plant genomic DNA and mating cells to form diploid transformants.
Combined, our approach promises to be an effective manufacturing platform for these precious (and sweet-smelling) compounds.